We are live on ! Find out more
PCML

Pavaki Capital Management LLC Portfolio holdings

AUM $287M
This Fund
S&P 500
This Quarter Est. Return
+11.86%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$287M
AUM Growth
+$51.4M
Cap. Flow
+$39.9M
Cap. Flow %
13.9%
Top 10 Hldgs %
50.36%
Holding
177
New
21
Increased
16
Reduced
3
Closed
14

Top Buys

Rank Stock Value
1
INTU icon
Intuit
INTU
+$13.4M
2
QCOM icon
Qualcomm
QCOM
+$9.16M
3
CVX icon
Chevron
CVX
+$4.19M
4
TXT icon
Textron
TXT
+$3.78M
5
MU icon
Micron Technology
MU
+$3M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$9.71M
2
DIS icon
Walt Disney
DIS
+$6.12M
3
OGN icon
Organon & Co
OGN
+$1.97M
4
SPHR icon
Sphere Entertainment
SPHR
+$1.39M
5
ESPR
Esperion Therapeutics
ESPR
+$1.12M

Sector Composition

Rank Sector Weight
1 Healthcare 18.12%
2 Technology 12.55%
3 Materials 9.73%
4 Energy 9.06%
5 Industrials 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDE icon
101
Coeur Mining
CDE
$17.9B
$405K 0.14%
24,795
– –
BEN icon
102
Franklin Resources
BEN
$17.2B
$399K 0.14%
12,000
– –
PTEN icon
103
Patterson-UTI
PTEN
$3.76B
$367K 0.13%
40,000
– –
ARR
104
Armour Residential REIT
ARR
$2.36B
$349K 0.12%
+20,000
New +$344K
CHRD icon
105
Chord Energy
CHRD
$7.39B
$343K 0.12%
3,000
– –
UAE icon
106
iShares MSCI UAE ETF
UAE
$321M
$342K 0.12%
18,000
– –
KURA icon
107
Kura Oncology
KURA
$850M
$329K 0.11%
30,000
– –
AU icon
108
AngloGold Ashanti
AU
$48.7B
$324K 0.11%
4,000
– –
DNOW icon
109
DNOW Inc
DNOW
$3.02B
$318K 0.11%
24,500
– –
AEM icon
110
Agnico Eagle Mines
AEM
$90.5B
$310K 0.11%
2,000
– –
PFE icon
111
Pfizer
PFE
$153B
$299K 0.1%
12,400
– –
MARA icon
112
Marathon Digital Holdings
MARA
$3.85B
$278K 0.1%
20,000
– –
CRSP icon
113
CRISPR Therapeutics
CRSP
$5.17B
$273K 0.1%
5,000
– –
PLD icon
114
CALL
Prologis
PLD
$133B
$271K 0.09%
2,000
– –
IAG icon
115
IAMGOLD
IAG
$10.6B
$266K 0.09%
16,800
– –
CTSH icon
116
Cognizant
CTSH
$26B
$263K 0.09%
6,800
– –
FAF icon
117
First American
FAF
$7.58B
$254K 0.09%
3,700
– –
THD icon
118
iShares MSCI Thailand ETF
THD
$372M
$253K 0.09%
+3,500
New +$250K
CPRX
119
DELISTED
Catalyst Pharmaceutical
CPRX
$251K 0.09%
8,000
– –
RMAX icon
120
RE/MAX Holdings
RMAX
$242M
$247K 0.09%
25,000
– –
WFRD icon
121
Weatherford International
WFRD
$6.22B
$245K 0.09%
+3,000
New +$304K
HYG icon
122
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$240K 0.08%
3,000
– –
PEB icon
123
Pebblebrook Hotel Trust
PEB
$2.05B
$233K 0.08%
12,000
– –
SHEL icon
124
Shell
SHEL
$245B
$233K 0.08%
3,000
– –
JOUT icon
125
Johnson Outdoors
JOUT
$505M
$230K 0.08%
5,000
– –
3 4
5
6 7

Similar funds

GCM
GoodHaven Capital Management Millburn, New Jersey $287M AUM 9.07% 1-Year Est. Return
AWM
Avaii Wealth Management Appleton, Wisconsin $287M AUM 29.75% 1-Year Est. Return
EA
Extract Advisors Calabasas, California $287M AUM
MAG
Mayfair Advisory Group Birmingham, Alabama $286M AUM 19.6% 1-Year Est. Return
PAM
PSquared Asset Management Zurich, Switzerland $287M AUM 58.62% 1-Year Est. Return
MM
Marnell Management Farmington Hills, Michigan $288M AUM
FCG
Financial Connections Group Corte Madera, California $288M AUM 15.87% 1-Year Est. Return
A
Argentarii Cincinnati, Ohio $286M AUM 32.04% 1-Year Est. Return

Pavaki Capital Management LLC's Q2 2026 Portfolio in Review

As of Q2 2026, Pavaki Capital Management LLC held 177 positions worth $287M, up 22% from $235M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Pavaki Capital Management LLC deployed $39.9M of net new capital in Q2 2026, opening 21 new positions and adding to 16 existing holdings. Its largest new stake was Intuit: 38,600 shares worth $10.1M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Intel, an estimated $9.71M trimmed.

  • Pavaki Capital Management LLC's largest Q2 2026 buy was Intuit: 38,600 shares worth $10.1M.
  • Pavaki Capital Management LLC added most to Chevron in Q2 2026, an estimated $4.19M increase.
  • Pavaki Capital Management LLC's biggest Q2 2026 reduction was Intel, cutting an estimated $9.71M.
  • Pavaki Capital Management LLC fully exited Organon & Co in Q2 2026, selling an estimated $1.97M.
  • Pavaki Capital Management LLC's ten largest holdings make up 50% of its $287M portfolio in Q2 2026.
  • Pavaki Capital Management LLC opened 21 new positions and closed 14 in Q2 2026.
  • Pavaki Capital Management LLC's portfolio value rose 22% quarter-over-quarter to $287M.

Based on Pavaki Capital Management LLC's 13F filing for Q2 2026, filed 7 Aug 2026.